Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer

ABSTRACT: RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer

PROVIDER: PRJNA421177 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6348580_1.fastq.gz	Fastqsanger.gz
	SRR6348580_2.fastq.gz	Fastqsanger.gz
	SRR6348581_1.fastq.gz	Fastqsanger.gz
	SRR6348581_2.fastq.gz	Fastqsanger.gz
	SRR6348582_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer

Project description:RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer

| PRJNA421177 | ENA

RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer

Project description:Purpose:The goals of this study are using next generation sequencing to identify differentially expressed genes by analyzing knockdown of MIR100HG in triple-negative breast cancer

2018-12-04 | GSE107717 | GEO

Mycobacterium triplex

Project description:Mycobacterium triplex genome

| PRJEB5744 | ENA

Mycobacterium triplex

Project description:Mycobacterium triplex overview

| PRJNA247427 | ENA

RNAseq of triple negative breast cancer samples

Project description:RNAseq of triple negative breast cancer samples

| PRJNA853278 | ENA

CdLS NeuN-negative RNAseq

Project description:CdLS NeuN-negative RNAseq

| PRJNA631220 | ENA

RNAseq of triple negative breast cancer samples

Project description:We report RNAseq data from tumors obtained from patients with triple negative breast cancer Eight patients with II-III stageTNBC diagnosis (only one patient with IV oligometastatic stage) were included in the study. All patients received neoadjuvant chemotherapy based on sequential anthracyclines and taxanes ± platinum salts plus radiation therapy. Seven patients were evaluable for response and pathological complete response (RCB=0) was reached in 71.4% of the patients (2 patients with RCB=2). No patients received adjuvant systemic therapy.Tumor biopsies were obtained for RNAseq studies.

2022-10-20 | GSE206998 | GEO

Chemoproteomic profiling unveils binding and functional diversity of endogenous proteins that interact with endogenous triplex DNA

Project description:Triplex DNA structures, formed by a third DNA strand wrapped around the major groove of double helix, are key molecular regulators and genomic threats that are pharmacologically exploitable. However, the regulatory network governing triplex DNA dynamics are poorly understood. Here we performed chemoproteomic profiling of triplex DNA interactome in live cells to address this knowledge gap. We developed and validated a chemical probe that exhibits exceptional specificity for recognizing triplex DNA structures. By employing a co-binding-mediated proximity capture strategy, we enriched triplex DNA interactome for quantitative proteomics analysis. This enabled the identification of a comprehensive list of triplex DNA interacting proteins, characterized by diverse binding properties and regulatory mechanisms in native chromatin context. As a demonstration, we further validated DDX3X as the first ATP-independent helicase capable of resolving triplex DNA structures with 5' overhangs on the third DNA strand to prevent triplex-DNA-induced DNA damages. Overall, our triplex DNA interactome offers a valuable resource for investigating the biology of triplex DNA in both health and disease.

2024-07-17 | GSE257561 | GEO

shRNA off target analysis via RNAseq

Project description:shRNAs were assessed for off-target effects by comparing the gene expression profiles of cells that they had been infected into. shRNAs designed with the shERWOOD algorithm and house in the ultramir microRNA scafold were found to have very little off targeting. Purpose: A major detriment to RNAi is off-targeting. We wished to assess the level of off targeting of microRNA (ultramiR) housed shERWOOD shRNAs as compared to similar shRNAs in the TRC collection. Methods: 5 shRNAs targeting each of two genes were infected into the 4T1 cell line. For each gene one shRNA was selected from the TRC collection and one based on the shERWOOD algorithm. For each gene, the exrpession profiles of the corresponding shRNA infected cells were compared using RNAseq. Conclusions: Highly similar profiles were observed between shERWOOD selected shRNAs. TRC shRNAs produced profiles indicative of off-targeting.

2014-11-24 | E-GEOD-62184 | biostudies-arrayexpress

Mycobacterium triplex

Project description:Whole genome sequencing of Mycobacterium triplex, an opportunistic pathogen

| PRJDB2636 | ENA